Dipeptidyl Peptidase Inhibitors
Learn MoreFTO inhibitors are a class of pharmaceutical compounds that have shown promise in the field of obesity and metabolic disorders FTO or Fat Mass and Obesity-associated protein has been identified as a key regulator of energy metabolism and body weight By inhibiting the activity of FTO these inhibitors have the potential to modulate energy homeostasis and offer a novel approach to managing conditions related to excess weight gain With mounting evidence supporting their efficacy FTO inhibitors may represent a promising therapeutic avenue for addressing the global obesity epidemic and improving overall health outcomes
Catalog Number | Chemical Name | CAS # | Price |
---|---|---|---|
BC-0448 | Radicicol | 12772-57-5 | Online Inquiry |
EI-0399 | Bisantrene dihydrochloride | 78186-34-2 | Online Inquiry |
EI-0457 | Brequinar Sodium | 96201-88-6 | Online Inquiry |
EI-0972 | FB23-2 | 2243736-45-8 | Online Inquiry |
EI-1430 | Meclofenamic acid sodium salt | 6385-02-0 | Online Inquiry |
EI-1881 | Rhein | 478-43-3 | Online Inquiry |
FTO inhibitors are a crucial tool in the field of obesity and metabolic research These inhibitors specifically target the FTO enzyme which is known to play a role in regulating energy balance and body weight By inhibiting FTO activity researchers can gain a deeper understanding of how this enzyme contributes to obesity and can potentially develop new therapeutic strategies for managing weight loss and improving metabolic health
In addition to their role in obesity research FTO inhibitors also hold promise in the field of cancer Studies have shown that FTO overexpression is associated with various types of cancer including leukemia and breast cancer By inhibiting FTO researchers hope to disrupt the cancer-promoting effects of this enzyme and potentially develop new targeted therapies for cancer treatment
Furthermore FTO inhibitors have implications in the field of neurodegenerative disorders such as Alzheimer's disease Research has shown that FTO plays a role in regulating cognitive function and neuronal health By inhibiting FTO scientists aim to explore the potential therapeutic benefits of targeting this enzyme in preventing or slowing down the progression of neurodegenerative diseases
Overall FTO inhibitors have a wide range of applications in biomedical research including obesity cancer and neurodegenerative disorders These inhibitors offer exciting opportunities for understanding disease mechanisms and developing innovative treatments and interventions
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.